John Baker (Senior Vice President, Abcam Plc)
Over the past 20 years, Abcam has established itself as a global leader in high-quality biological reagents - the key bio-sensors enabling life scientists worldwide in research, drug discovery and diagnostics.
Learn about how a local Cambridge start-up successfully expanded into a thriving publicly-listed global business, with 1,100 employees at 11 sites working at the forefront of life sciences innovation.
This talk will review Abcam’s technologies, and describe how its partnering & collaboration model with both established and novel instrumentation and clinical platforms is supporting the advance of ground-breaking analytical approaches that are accelerating the development of tomorrow’s medicines.